Sanofi SA
NASDAQ:SNY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
NASDAQ:SNY
|
FR |
|
D
|
Dowlais Group Plc
OTC:DWLAF
|
UK |
|
Visa Inc
NYSE:V
|
US |
|
U
|
Unilever PLC
BMV:ULN
|
UK |
|
C
|
Compass Group PLC
OTC:CMPGY
|
UK |
|
I
|
Iberdrola SA
XMUN:IBE1
|
ES |
|
Truworths International Ltd
OTC:TRWKF
|
ZA |
|
T
|
TAG Immobilien AG
OTC:TAGOF
|
DE |
|
A
|
Abbott Laboratories
SWB:ABL
|
US |
|
B
|
Beiersdorf AG
DUS:BEI
|
DE |
|
B
|
Burlington Stores Inc
XBER:BUI
|
US |
|
Spinnova Oyj
F:9HP
|
FI |
|
A
|
Alibaba Group Holding Ltd
OTC:BABAF
|
CN |
|
Clemondo Group AB (publ)
F:N17
|
SE |
|
FIRST BANK (Hamilton)
NASDAQ:FRBA
|
US |
|
S
|
Synopsys Inc
SWB:SYP
|
US |
|
A
|
Amadeus IT Group SA
XMUN:AI3A
|
ES |
|
V
|
Veeco Instruments Inc
SWB:VEO
|
US |
|
A
|
Atlas Copco AB
XBER:ACO4
|
SE |
|
G
|
Glencore PLC
XHAM:8GC
|
CH |
|
Sony Group Corp
OTC:SNEJF
|
JP |
|
KDDI Corp
F:DIP0
|
JP |
|
Exxaro Resources Ltd
OTC:EXXAF
|
ZA |
|
Northwest Bancshares Inc
NASDAQ:NWBI
|
US |
Bankruptcy Probability
Sanofi SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sanofi SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Sanofi SA
PAR:SAN
|
90.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
618.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
317B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
184.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
149.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
48.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
237.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sanofi SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sanofi SA has total debt of 13.8B EUR. This includes both short-term (0 EUR) and long-term (13.8B EUR) debt.
You can find a full breakdown on its Balance Sheet.
